Search results
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 5 days agoEli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a...
3 Growth Stocks You Can Buy Right Now Without Any Hesitation | The Motley Fool
The Motley Fool· 13 hours agoThree Motley Fool contributors believe they've identified good picks -- and they're all big biotech...
Here is What to Know Beyond Why Novo Nordisk A/S (NVO) is a Trending Stock
Zacks via Yahoo Finance· 5 days agoNordisk (NVO) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good...
A Life Expansion Revolution Is Coming: 3 Stocks That Could Lead the Charge
Motley Fool via Yahoo Finance· 4 days agoLilly's 2019 partnership with Atomwise, an AI-driven drug discovery company, started the company...
Sarepta’s stock gains after Pfizer’s Duchenne trial failure - Boston Business Journal
The Business Journals· 2 days agoSarepta Therapeutics, a Cambridge drugmaker known for its Duchenne muscular dystrophy treatments,...
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 3 days agoAbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want...
Drug-resistant "dual mutant" flu strains now being tracked in U.S., CDC says
CBS News· 3 days agoAt least two human cases of the new so-called "dual mutant" strains of H1N1 influenza have been...
Want to Get Richer? 2 Top Stocks to Buy Now and Hold Forever.
Motley Fool via Yahoo Finance· 3 days agoEli Lilly's recently approved drug can potentially help prescribed users shed excess pounds and...
A successful Alzheimer's drug will help Eli Lilly join the $1 trillion club
CNBC· 4 days agos drug that moved one step closer to market this week. A key advisory panel for the Food and Drug...
The Latest | The US Supreme Court rules to preserve access to the abortion pill mifepristone
The News-Times· 2 days agoThe U.S. Supreme Court on Thursday ruled unanimously to preserve access to the drug most commonly...
